Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yelena Janjigian, MD
CONTACT
Samuel Cytryn, MD
CONTACT
Lead
Memorial Sloan Kettering Cancer Center
With
Eligible patients will receive 8 peri-operative cycles of pembrolizumab and trastuzumab with chemotherapy (fluoropyrimidine/oxaliplatin doublet for patients initially enrolled and subsequently FLOT \[5-fluorouracil, oxaliplatin and docetaxel\] followed by pembrolizumab and trastuzumab maintenance to complete 1 total year of therapy.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted